Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease

被引:18
作者
Lumbreras, M.
Baamonde, C.
Martinez-Cue, C.
Lubec, G.
Cairns, N.
Salles, J.
Dierssen, M.
Florez, J.
机构
[1] Univ Cantabria, Fac Med, Dev Neurobiol Lab, Dept Physiol & Pharmacol, Santander 39011, Spain
[2] Med Univ Vienna, Dept Pediat, Vienna, Austria
[3] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
[4] Univ Basque Country, Fac Pharm, Dept Pharmacol, Vitoria, Spain
[5] Genom Regulat Ctr, Program Genes & Dis, Barcelona, Spain
关键词
adenylyl cyclase; phospholipase C; cerebral cortex; cerebellum; Down syndrome; Alzheimer's disease;
D O I
10.1007/s00726-005-0272-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Premature aging and neuropathological features of Alzheimer's disease (AD) are commonly observed in Down syndrome (DS). Based on previous findings in a DS mouse model, the function of signaling pathways associated with adenylyl cyclase (AC) and phospholipase C (PLC) was assessed in cerebral cortex and cerebellum of age-matched adults with DS, AD, and controls. Basal production of cAMP was reduced in DS but not in AD cortex, and in both, DS and AD cerebellum. Responses to GTP gamma S, noradrenaline, SKF 38393 and forskolin were more depressed in DS than in AD cortex and cerebellum. Although no differences in PLC activity among control, DS and AD cortex were observed under basal and GTP gamma S- or Ca-stimulated conditions, the response of DS cortex to serotonergic and cholinergic stimulation was depressed, and that of AD was only impaired at cholinergic stimulation. No differences were documented in cerebellum. Our results demonstrate that PLC and AC were severely disturbed in the aged DS and AD brains, but the alterations in DS were more severe, and differed to some extent from those observed in AD.
引用
收藏
页码:449 / 456
页数:8
相关论文
共 40 条
[1]   Relation of age and apolipoprotein E to cognitive function in Down syndrome adults [J].
Alexander, GE ;
Saunders, AM ;
Szczepanik, J ;
Strassburger, TL ;
Pietrini, P ;
Dani, A ;
Furey, ML ;
Mentis, MJ ;
Roses, AD ;
Rapoport, SI ;
Schapiro, MB .
NEUROREPORT, 1997, 8 (08) :1835-1840
[2]   10 years of genomics, chromosome 21, and Down syndrome [J].
Antonarakis, SE .
GENOMICS, 1998, 51 (01) :1-16
[3]   FETAL HUMAN BRAIN EXHIBITS A PRENATAL PEAK IN THE DENSITY OF SEROTONIN 5-HT1A RECEPTORS [J].
BARPELED, O ;
GROSSISSEROFF, R ;
BENHUR, H ;
HOSKINS, I ;
GRONER, Y ;
BIEGON, A .
NEUROSCIENCE LETTERS, 1991, 127 (02) :173-176
[4]   LIPID ABNORMALITIES IN THE BRAIN IN ADULT DOWNS-SYNDROME AND ALZHEIMERS-DISEASE [J].
BROOKSBANK, BWL ;
MARTINEZ, M .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1989, 11 (03) :157-185
[5]  
CORK LC, 1990, AM J MED GENET, P282
[6]  
Cowburn RF, 2001, BIOCHEM SOC SYMP, V67, P163
[7]   CHOLINERGIC AND SEROTONERGIC STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IS DECREASED IN ALZHEIMERS-DISEASE [J].
CREWS, FT ;
KURIAN, P ;
FREUND, G .
LIFE SCIENCES, 1994, 55 (25-26) :1993-2002
[8]  
DAVISSON MT, 2002, PHENOTYPIC MAPPING D, P117
[9]   Reduced phospholipase C-β activity and isoform expression in the cerebellum of Ts65Dn mouse:: A model of Down syndrome [J].
de Azúa, IR ;
Lumbreras, MA ;
Zalduegui, A ;
Baamonde, C ;
Dierssen, M ;
Flórez, J ;
Sallés, J .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (04) :540-550
[10]   Functional organization of PLC signaling microdomains in neurons [J].
Delmas, P ;
Crest, M ;
Brown, DA .
TRENDS IN NEUROSCIENCES, 2004, 27 (01) :41-47